Clinical trial
Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP)
NCT05047731 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP)
- Lead sponsor
- University of Alberta
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 20, 2021
- Completion date
- November 30, 2025
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.